CH Robinson (CHRW) Analysis - Buy, Sell, Hold?

C.H. Robinson Worldwide (CHRW) is in Stage 1: Acute Distribution / Early Bottoming Attempt. The stock gapped down sharply on Oct. 5 after announcing the RXO acquisition, closing near $140.96, down roughly 10.65% from the previous close, with volume several times its average. It is now below the 10-day, 50-day and 200-day moving averages; RSI near 38 and negative MACD confirm weakness, although the stock is approaching its 52-week-low region.

1: Chart Analysis & Price Action Assessment

• Overall trend: The short-, medium- and long-term trends are bearish. CHRW trades below its 10-day SMA near $149.81, 50-day SMA near $153.39 and 200-day SMA near $172.32.
• Recent price behavior: CHRW opened near $140.67, traded between approximately $132.05 and $144.75, and closed near $140.96. This represented a decline of roughly 10.65% from the previous close.
• Gap behavior: The stock opened well below the prior close near $157.72, creating a major downside gap. Such gaps often become important resistance zones during any subsequent rebound.
• Candlestick behavior: The session produced a wide, high-volatility bar with an initial low near $132.05 and a partial recovery into the close. The recovery from the low is mildly constructive, but the stock still closed far below the prior close.
• Moving-average structure: Price is below all three major moving averages. The $149.81 to $153.39 region is the first moving-average resistance cluster, while the $172.32 200-day average is a much higher trend-repair barrier.

2: Volume & Volatility Analysis

• Volume: Oct. 5 volume was approximately 7.69 million shares, compared with an average daily volume near 1.72 million shares. This was more than four times average.
• Volume-price relationship: A decline of approximately 10.65% on more than four times average volume confirms acute distribution and a major repricing event. The partial recovery from $132.05 does not offset the bearish significance of the gap-down.
• Volatility: Volatility was exceptionally high. The session range was approximately $12.70, or roughly 9% of the closing price. The gap itself added another major source of event risk.
• Momentum indicators: RSI was reported near 38.45, indicating weak but not deeply oversold momentum. MACD near -0.065 generated a sell signal, while the long-term moving-average structure remained bearish.
• Current interpretation: CHRW is experiencing event-driven distribution. A rebound is possible after such a sharp fall, but it should initially be treated as a volatility-driven reaction rather than evidence of a durable bottom.

3: Phase Classification

4: Final Summary & Recommended Action

Based on the gap-down, extreme volume, moving-average structure, volatility and momentum, CHRW is currently in Stage 1: Acute Distribution / Early Bottoming Attempt.

Key Observations

• Trend Direction: Bearish across short-, medium- and long-term moving averages.
• Volume Behavior: Extremely elevated—more than four times average—confirming event-driven distribution.
• Volatility: Extremely high; the Oct. 5 range was roughly 9% of price.
• Momentum: Weak but not deeply oversold; RSI near 38 and MACD negative.
• Immediate Support: $132.05 to $135.00.
• Key Support: $123.64 to $127.50.
• Immediate Resistance: $144.75 to $149.81.
• Major Resistance: $153.39 to $157.72.
• Gap Resistance: $157.72 to $164.00.
• Long-Term Resistance: $172.32.

Suggested Strategy

• Fresh buyers should avoid attempting to catch the stock immediately after a gap-down of this magnitude and volume.
• Existing holders should treat $132.05 to $135.00 as the immediate risk-control zone.
• A rebound above $144.75 to $149.81 would provide an initial stabilization signal but would not fully repair the breakdown.
• A sustained recovery above $153.39 to $157.72 would improve the setup and begin filling the downside gap.
• A move above $172.32 would be required to repair the longer-term moving-average structure and support a possible Stage 2 transition.
• A close below $132.05, particularly on continued heavy volume, would favor waiting for a new base rather than averaging down aggressively.
• Track the RXO acquisition terms, stock dilution, leverage and debt reduction, share-repurchase suspension, freight demand, brokerage margins, integration risk and management guidance.

This analysis is educational and based on publicly reported market data available through Oct. 5, 2026. It is not investment advice. Confirm current price, volume, company disclosures, acquisition terms and your own risk tolerance before trading or investing.